Advanced infrared imaging microscope for pharma and life science applications

Bruker Corporation has introduced the LUMOS™ II ILIM, a quantum cascade laser (QCL)-based infrared imaging microscope that sets new benchmarks in speed and resolution. Designed to meet the needs of pharmaceutical and life science researchers, the LUMOS II ILIM enables ultrafast infrared imaging of large sample areas with exceptional spatial detail.

The microscope incorporates a patented coherence reduction technology that minimises artifacts in both transmission and reflection modes, delivering artifact-free infrared laser imaging. With a large field of view and full automation, it facilitates rapid analysis of complex biological tissues.

Dr Guillaume Mabilleau, Clinical Bone Pathologist at Centre Hospitalier Universitaire Angers, France, commented: “The speed and quality of infrared imaging provided by this microscope are remarkable. Its ease of use and high throughput, powered by QCL technology, mark a significant advancement in clinical research. We are excited about the potential applications in improving the diagnosis and treatment of bone diseases.”

The LUMOS II ILIM leverages AI-driven data evaluation to advance research in pharmaceuticals, life sciences, and disease studies. Its integration with Bruker’s MALDI Imaging technology enables multimodal tissue characterisation with deeper analytical insights. Additionally, the system is well-suited for pharmaceutical tablet inspection and particle identification, offering automated sampling capabilities.

For added flexibility, the LUMOS II ILIM includes a Python interface, allowing users to customise workflows to meet specific research needs.

More information online